Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2500 of 6351
-
New hope for incurable cancer? expert team aims to find novel treatments
Knowledge-focused Recruiting nowThis study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Remdesivir shows promise in severe COVID-19 patients
Disease control CompletedThis study is a retrospective cohort trial to assess the efficacy of remdesivir in hospitalized adult patients diagnosed with COVID-19. The study is a multicenter trial which will be carried out on different sites in France. This trial is retrospective and will analyze the data c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Stent vs. scalpel: can a tiny tube replace surgery for leg artery disease?
Disease control OngoingThe SUPERSURG RCT trial investigates the efficacy and safety of the endovascular treatment of stenosis or restenosis in the common femoral artery (CFA) of patients presenting with Rutherford classification 2,3 or 4 with a Supera Vascular Mimetic Implant of Abbott, compared to cla…
Sponsor: KANDO Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Timed eating may reverse prediabetes in overweight individuals
Disease control OngoingWe evaluated the effects of Time-Restricted Eating (TRE) regimen on Impaired Glucose Regulation (IGR) in comparison with overweight/obese patients receiving standard of care over 12 months.
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Texting teens to treatment: can a simple SMS boost attendance?
Disease control CompletedThe research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Lifestyle showdown: can diet and exercise replace MS drugs?
Disease control OngoingA key question in efforts to reduce symptoms and improve quality of life for multiple sclerosis (MS) patients is whether a therapeutic lifestyle (diet, stress reduction and exercise) is inferior to disease-modifying drug treatments in terms of reducing multiple sclerosis related …
Sponsor: Terry L. Wahls • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Heart patients may soon skip clinic visits with new remote monitoring trial
Disease control CompletedThis is a Canadian multicenter randomized controlled trial to assess remote patient management. Patients will be randomized to remote patient management with VIRTUES versus usual care, and will be stratified by RemoteView vs no RemoteView utilization, as well as by center.
Sponsor: Ratika Parkash • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New parenting program aims to strengthen bonds for moms battling opioid addiction
Knowledge-focused CompletedThis study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up (mABC) Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified A…
Sponsor: University of Delaware • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Pressurized oxygen shows promise for severe COVID-19 in small trial
Symptom relief CompletedThe 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic.So far, no specific treatment has proven efficacy. Recent case series reported the use of Hyperbaric Oxygen Therapy (HBOT) on 5 severe COVID-19 patients who developed respiratory insufficiency. HBOT mecha…
Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can a global registry unlock the best way to treat tricky heart blockages?
Knowledge-focused Recruiting nowCoronary bifurcation lesions are lesions (or blockages) that occur at or near the intersection of a major coronary artery and one of the arteries' side branches. Numerous techniques and devices have been developed to treat coronary bifurcations; however, these types of lesions r…
Sponsor: Minneapolis Heart Institute Foundation • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Promising combo tackles rare lymphoma in early trial
Disease control CompletedThis is a prospective single arm, multi-center, phase II clinical trial to observe the efficacy and safety of VR-CAP (Bortezomib and Rituximab-Cyclophosphamide, Epirubicin and Prednisone) in the first-line treatment for patients with marginal zone lymphoma.
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
What happens to the immune system after COVID-19? a major study aims to find out.
Knowledge-focused Recruiting nowLIINC is a study of volunteers who were previously infected with SARS-CoV-2 (also known as novel coronavirus or COVID-19) who have recovered from acute infection. The study is designed to provide a specimen bank of samples with carefully characterized clinical data. LIINC specime…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
Disease control CompletedImplementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Malaria drug combo shows promise against COVID-19 in early trial
Disease control Stopped earlyThis study will evaluate anti-malarial/anti-infective single-agent and in combination for patients with confirmed COVID-19 infection. The first combination to be evaluated is atovaquone and azithromycin.
Phase 2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat cancers
Disease control OngoingIn phase Ia study, the safety and tolerability of SI-B001 in patients with locally advanced or metastatic epithelial malignancies will be investigated to determine the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) of SI-B001. In the phase Ib study, the safety and to…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
COVID prevention drugs fail in hospital worker trial
Prevention CompletedThe Investigators propose to set up a preventive trial of infection in hospital workers at risk of coronavirus infection by comparing the rate of SARS-Cov-2 infection in a population of negative SARS-Cov-2 hospital workers receiving preventively azithromycin, hydroxychloroquine o…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Spit test could replace swabs for COVID-19 diagnosis
Diagnosis CompletedThe objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1. to compensate for the risk of a shortage of diagnostic kits, reagents and mater…
Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
Lying face-down with high-flow oxygen may help COVID-19 patients avoid breathing tubes
Knowledge-focused CompletedA subset of patients with COVID-19 develops acute respiratory failure and acute respiratory distress syndrome (ARDS) (1). The use of invasive mechanical ventilation for the treatment of these conditions is associated with high mortality rates (2,3). The use of high-flow nasal oxy…
Sponsor: Hospital Privado de Comunidad de Mar del Plata • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New saliva test could diagnose COVID-19 in under an hour
Diagnosis CompletedCoronavirus disease 2019 or COVID-19 is a highly contagious infectious disease. Symptoms of the disease are non-specific (fever, cough, dyspnea and fatigue), common with many seasonal viruses, which complicates the diagnosis. For mild forms, which represent the vast majority of c…
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
COVID-19 ICU survivors may face unique long-term disabilities, study suggests
Knowledge-focused OngoingThe investigators hypothesize that those with respiratory failure due to COVID-19 will have different burdens of mental and physical disability than those with respiratory failure who do not have COVID-19. Detecting these potential differences will lay an important foundation for…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC